AAAAAA

   
Results: 1-25 | 26-39 |
Results: 26-39/39
PROGNOSTIC IMPLICATIONS OF KARYOTYPE IN 159 NEWLY-DIAGNOSED ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: CAMPBELL LJ MICHAEL PM WHITE JS MATTHEWS JP
Citation: Lj. Campbell et al., PROGNOSTIC IMPLICATIONS OF KARYOTYPE IN 159 NEWLY-DIAGNOSED ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 86(10), 1995, pp. 678-678
PROGNOSTIC-SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN ADULT ACUTE MYELOID-LEUKEMIA PATIENTS TREATED WITH HIGH-DOSE CYTARABINE
Authors: GARSON OM MATTHEWS JP BISHOP JF
Citation: Om. Garson et al., PROGNOSTIC-SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN ADULT ACUTE MYELOID-LEUKEMIA PATIENTS TREATED WITH HIGH-DOSE CYTARABINE, Blood, 86(10), 1995, pp. 2386-2386
IDARUBICIN, CYTARABINE IN STANDARD OR HIGH-DOSE, AND ETOPOSIDE + - LENOGRASTIM (G-CSF) FOR ADULT ACUTE MYELOID-LEUKEMIA (AML) - COMBINATIONS GIVING HIGH REMISSION RATES/
Authors: LOWENTHAL RM BRADSTOCK KM MATTHEWS JP ENNO A GILL D PAGE FJ ROONEY KF TAYLOR KM
Citation: Rm. Lowenthal et al., IDARUBICIN, CYTARABINE IN STANDARD OR HIGH-DOSE, AND ETOPOSIDE + - LENOGRASTIM (G-CSF) FOR ADULT ACUTE MYELOID-LEUKEMIA (AML) - COMBINATIONS GIVING HIGH REMISSION RATES/, Blood, 86(10), 1995, pp. 3059-3059
THE INFLUENCE OF INDUCTION CHEMOTHERAPY DOSE AND DOSE INTENSITY ON THE DURATION OF REMISSION IN ACUTE MYELOID-LEUKEMIA
Authors: BISHOP JF MATTHEWS JP YOUNG G SZER J JOSHUA DE DODDS A LAIDLAW CR COBCROFT R HERRMAN R MA D PAGE FJ
Citation: Jf. Bishop et al., THE INFLUENCE OF INDUCTION CHEMOTHERAPY DOSE AND DOSE INTENSITY ON THE DURATION OF REMISSION IN ACUTE MYELOID-LEUKEMIA, Leukemia & lymphoma, 15(1-2), 1994, pp. 79-84
THE ROLES OF PATIENT AND OBSERVER ASSESSMENTS IN ANTIEMETIC TRIALS
Authors: OLVER IN MATTHEWS JP BISHOP JF SMITH RA
Citation: In. Olver et al., THE ROLES OF PATIENT AND OBSERVER ASSESSMENTS IN ANTIEMETIC TRIALS, European journal of cancer, 30A(9), 1994, pp. 1223-1227
A RANDOMIZED DOUBLE-BLIND CROSSOVER STUDY OF DOMPERIDONE AND PROCHLORPERAZINE SUPPOSITORIES FOR CONTROLLING EMESIS IN OUTPATIENTS RECEIVINGCHEMOTHERAPY
Authors: OLVER IN LAIDLAW CR MATTHEWS JP BISHOP JF HAYES AM WOLF M TONER GC
Citation: In. Olver et al., A RANDOMIZED DOUBLE-BLIND CROSSOVER STUDY OF DOMPERIDONE AND PROCHLORPERAZINE SUPPOSITORIES FOR CONTROLLING EMESIS IN OUTPATIENTS RECEIVINGCHEMOTHERAPY, European journal of cancer, 30A(4), 1994, pp. 426-429
RANDOMIZED COMPARISON OF MACOP-B WITH CHOP IN PATIENTS WITH INTERMEDIATE-GRADE NON-HODGKINS-LYMPHOMA
Authors: COOPER IA WOLF MM ROBERTSON TI FOX RM MATTHEWS JP STONE JM DING JC DART G MATTHEWS J FIRKIN FC LOWENTHAL RM IRONSIDE P
Citation: Ia. Cooper et al., RANDOMIZED COMPARISON OF MACOP-B WITH CHOP IN PATIENTS WITH INTERMEDIATE-GRADE NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 12(4), 1994, pp. 769-778
COMPLEX EXPRESSION OF KERATINS IN GOLDFISH OPTIC-NERVE
Authors: DRUGER RK GLASGOW E FUCHS C LEVINE EM MATTHEWS JP PARK CY SCHECHTER N
Citation: Rk. Druger et al., COMPLEX EXPRESSION OF KERATINS IN GOLDFISH OPTIC-NERVE, Journal of comparative neurology, 340(2), 1994, pp. 269-280
LOW VERSUS STANDARD-DOSE G-CSF PROPHYLAXIS AFTER CHEMOTHERAPY - A RANDOMIZED CROSSOVER COMPARISON
Authors: TONER GC LAIDLAW C MILLWARD MJ RISCHIN D WOLF MM JANUSZEWICZ EH MATTHEWS JP BISHOP JF
Citation: Gc. Toner et al., LOW VERSUS STANDARD-DOSE G-CSF PROPHYLAXIS AFTER CHEMOTHERAPY - A RANDOMIZED CROSSOVER COMPARISON, Blood, 84(10), 1994, pp. 10000026-10000026
THE STUDY OF COMBINATION THERAPY PLUS OR MINUS ROFERON-A IN MULTIPLE-MYELOMA
Authors: JOSHUA DE PENNY R BALDWIN R LAIDLAW CR MATTHEWS JP
Citation: De. Joshua et al., THE STUDY OF COMBINATION THERAPY PLUS OR MINUS ROFERON-A IN MULTIPLE-MYELOMA, Blood, 84(10), 1994, pp. 10000179-10000179
HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) IN INDUCTION PROLONGS REMISSION IN ACUTE MYELOID-LEUKEMIA (AML) - UPDATED RESULTS OF A RANDOMIZED PHASE-III TRIAL
Authors: BISHOP JF MATTHEWS JP YOUNG GA SZER J GILLETT A JOSHUA D BRADSTOCK K ENNO A WOLF M FOX R COBCROFT R HERRMANN R VANDERWEYDEN M JUNEJA S
Citation: Jf. Bishop et al., HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) IN INDUCTION PROLONGS REMISSION IN ACUTE MYELOID-LEUKEMIA (AML) - UPDATED RESULTS OF A RANDOMIZED PHASE-III TRIAL, Blood, 84(10), 1994, pp. 10000232-10000232
DYNAMICS OF TIDAL MIXING FRONTS IN THE NORTH-SEA
Authors: HILL AE JAMES ID LINDEN PF MATTHEWS JP PRANDLE D SIMPSON JH GMITROWICZ EM SMEED DA LWIZA KMM DURAZO R FOX AD BOWERS DG
Citation: Ae. Hill et al., DYNAMICS OF TIDAL MIXING FRONTS IN THE NORTH-SEA, Philosophical transactions-Royal Society of London. Physical sciences and engineering, 343(1669), 1993, pp. 431-446
INHIBITION OF TUMOR PRODUCTION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR BY 1-ALPHA,25-DIHYDROXYVITAMIN D-3 REDUCES TUMOR MOTILITY AND METASTASIS
Authors: YOUNG MRI HALPIN J HUSSAIN R LOZANO Y DJORDJEVIC A DEVATA S MATTHEWS JP WRIGHT MA
Citation: Mri. Young et al., INHIBITION OF TUMOR PRODUCTION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR BY 1-ALPHA,25-DIHYDROXYVITAMIN D-3 REDUCES TUMOR MOTILITY AND METASTASIS, Invasion & metastasis, 13(4), 1993, pp. 169-177
IDARUBICIN, CYTOSINE-ARABINOSIDE IN STANDARD OR HIGH-DOSE, AND ETOPOSIDE - COMBINATIONS GIVING HIGH REMISSION RATES IN ADULT ACUTE MYELOID-LEUKEMIA (AML) - PILOT-STUDIES OF THE AUSTRALIAN LEUKEMIA STUDY-GROUP (ALSG)
Authors: LOWENTHAL RM MATTHEWS JP BISHOP JF BUNCE IH COBCROFT RG ELIADIS P HARVEY MP HERMANN RP JANUSZEWICZ EH KIMBER RI LINDEMAN R MANOHARAN A PAGE FJ ROONEY KF ROSENFELD D TAYLOR KM WILEY JS WOLF MM YOUNG GAR
Citation: Rm. Lowenthal et al., IDARUBICIN, CYTOSINE-ARABINOSIDE IN STANDARD OR HIGH-DOSE, AND ETOPOSIDE - COMBINATIONS GIVING HIGH REMISSION RATES IN ADULT ACUTE MYELOID-LEUKEMIA (AML) - PILOT-STUDIES OF THE AUSTRALIAN LEUKEMIA STUDY-GROUP (ALSG), Blood, 82(10), 1993, pp. 10000328-10000328
Risultati: 1-25 | 26-39 |